Macular Degeneration Dry clinical trials

Explore recruiting macular degeneration dry clinical trials.

Recruiting macular degeneration dry studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Macular Degeneration Dry trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

ReNEW: A Phase 3, Randomized, Double-Masked, Placebo-Controlled Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects who have Dry Age-Related Macular Degeneration (Dry AMD)

Italy, Hungary, Germany, Czechia, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Macular Degeneration Dry trials by city

Macular Degeneration Dry clinical trials

Recruiting macular degeneration dry studies right now

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy)

A Study to Evaluate the Safety and Effect of TO-O-1007 Intravitreal Implant in Subjects With Geographic Atrophy

Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration

AVIGA3 (Cohort 2.0)

Phase 1 Study of C.001 in Retinal Degeneration

Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD

A Phase 1/2 Study to Evaluate the Safety and Efficacy of Intravitreal Administration of BS01 in Patients With Geographic Atrophy Secondary to Dry AMD

Phase 2 Study of ADX-038 in Participants With Geographic Atrophy

Long-Term Analysis of DImethyl Fumarate, to Slow the Growth of Areas of Geographic Atrophy

Photobiomodulation in Dry Age Related Macular Degeneration

Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration

Also recruiting in Europe

ReNEW: A Phase 3, Randomized, Double-Masked, Placebo-Controlled Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects who have Dry Age-Related Macular Degeneration (Dry AMD)

Macular Degeneration Dry trials by city

Other conditions